Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Return on Assets: 2020-2025

Historic Return on Assets for Avidity Biosciences (RNA) over the last 5 years, with Sep 2025 value amounting to -0.31%.

  • Avidity Biosciences' Return on Assets fell 13.00% to -0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.31%, marking a year-over-year decrease of 13.00%. This contributed to the annual value of -0.29% for FY2024, which is 4.00% up from last year.
  • As of Q3 2025, Avidity Biosciences' Return on Assets stood at -0.31%, which was up 2.60% from -0.32% recorded in Q2 2025.
  • In the past 5 years, Avidity Biosciences' Return on Assets ranged from a high of -0.19% in Q3 2024 and a low of -0.38% during Q3 2022.
  • Its 3-year average for Return on Assets is -0.28%, with a median of -0.31% in 2023.
  • Per our database at Business Quant, Avidity Biosciences' Return on Assets decreased by 16bps in 2021 and then increased by 15bps in 2024.
  • Avidity Biosciences' Return on Assets (Quarterly) stood at -0.28% in 2021, then declined by 5bps to -0.33% in 2022, then dropped by 3bps to -0.35% in 2023, then grew by 15bps to -0.20% in 2024, then dropped by 13bps to -0.31% in 2025.
  • Its Return on Assets stands at -0.31% for Q3 2025, versus -0.32% for Q2 2025 and -0.24% for Q1 2025.